SNGX · XBRL financial data

Soligenix financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (SNGX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	2,359	824	949	839	119	—
Cost of revenue	1,821	729	551	742	119	—
Gross profit	538	96	398	97	—	—
Research and development	10,146	8,389	7,944	3,313	5,224	7,486
General and administrative	3,979	4,847	6,693	4,483	4,216	4,360
Total operating expenses	19,125	13,237	14,637	7,795	9,439	11,845
Operating income (loss)	(18,587)	(13,141)	(14,239)	(7,698)	(9,439)	(11,845)
Interest expense	34	—	—	—	—	—
Other income (expense)	61	(275)	6	43	550	(12)
Income tax expense (benefit)	(837)	(865)	(1,155)	(1,768)	(409)	(507)
Net income (loss)	(17,689)	(12,551)	(13,798)	(6,141)	(8,267)	(11,080)
Earnings per share, basic‡ USD per share	(152.84)	(74.03)	(1,148.66)	(12.64)	(4.98)	(2.14)
Earnings per share, diluted‡ USD per share	(152.84)	(74.03)	(1,148.66)	(12.64)	(4.98)	(2.14)
Weighted average shares, basic‡ thousands of shares	115	168	12	485	1,660	5,189
Weighted average shares, diluted‡ thousands of shares	115	168	12	485	1,660	5,189

‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (February 2023); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-16 stock split (June 2024); filings made before it reported them unadjusted.
† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 54x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SNGX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	18,677	26,044	13,360	8,446	7,820	7,936
Total current assets	19,467	26,570	13,853	9,507	8,829	8,849
Property and equipment, net	24	22	18	12	6	9
Right-of-use asset	222	106	341	230	109	355
Total assets	19,891	26,870	14,280	9,797	8,966	9,236
Accounts payable	2,130	2,926	3,866	1,111	668	1,115
Accrued liabilities	2,638	2,957	2,308	2,418	2,359	1,982
Total current liabilities	6,081	6,291	16,517	6,152	4,848	3,699
Total deposits	1,000	250	—	—	—	—
Lease liability, non-current	—	—	234	112	—	244
Total liabilities	16,149	16,147	16,751	7,275	4,848	3,943
Accumulated deficit	(193,214)	(205,765)	(219,563)	(225,704)	(233,971)	(245,051)
Total stockholders' equity	3,742	10,723	(2,471)	2,522	4,118	5,292
Total liabilities and equity	19,891	26,870	14,280	9,797	8,966	9,236
Common shares outstanding (cover page)‡ thousands of shares	168	180	12	658	3,156	10,306

‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (February 2023); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 1-for-16 stock split (June 2024); filings made before it reported them unadjusted.
† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 54x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (SNGX's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(17,689)	(12,551)	(13,798)	(6,141)	(8,267)	(11,080)
Stock-based compensation	410	362	333	370	330	588
Depreciation and amortization	62	34	—	—	—	—
Net cash from operating activities	(11,454)	(11,740)	(12,649)	(8,604)	(8,404)	(10,267)
Purchases of property and equipment	—	—	—	—	—	6
Net cash from investing activities	(7)	(12)	(13)	—	—	(6)
Net cash from financing activities	24,677	19,058	77	3,664	7,762	10,389
Net change in cash	13,256	7,367	(12,684)	(4,913)	(627)	117

† Share count changed about 1/15 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
† Share count changed about 54x in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Soligenix	9,811	not reported	(1,707)*	21.8M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Target Group	14	1,381	(223)*	617.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Creative Medical Technology Holdings	8,714	0	(1,472)*	6.6M	5.9 quarters	Q2 FY26 10-QJun 30, 2026
Aspira Women's Health	477	17	(2,010)*	46.6M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Matinas BioPharma Holdings	761	not reported	(1,836)*	14.7M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Synlogic	13,183	0	(922)*	12.2M	14.3 quarters	Q2 FY26 10-QJun 30, 2026
China Pharma Holdings	305	948	(33)*	43.0M	9.3 quarters	Q2 FY26 10-QJun 30, 2026
Viskase Holdings	7,747	95,279	454*	14.3M	—	Q3 FY26 10-QSep 30, 2026
Xenetic Biosciences	6,472	661	(875)*	2.3M	7.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.